We are live on ! Find out more
ELAB icon

Elevai Labs
ELAB

11 hedge funds and large institutions have $322K invested in Elevai Labs in 2026 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

83% more funds holding

Funds holding: 6 → 11 (+5)

17% less capital invested

Capital invested by funds: $388K → $322K (-$65.8K)

Holders
11
Holders Change
+5
Holders Change %
+83.33%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$126K
2
Morgan Stanley
Morgan Stanley
New York
+$96.2K
3
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust
Pennsylvania
+$86.1K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$61K
5
Citadel Advisors
Citadel Advisors
Florida
+$52.4K

Top Sellers

Rank Fund Capital Flow
1
SSA
Schonfeld Strategic Advisors
New York
-$88.7K
2
IA
IFP Advisors
Florida
-$2.53K

ELAB Hedge Fund Activity: Q2 2026 in Review

11 of the 8,331 institutional investors tracked by Wall St. Rank reported a position in Elevai Labs (ELAB) for Q2 2026, worth a combined $322K — down 17% from $388K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ELAB positions and 1 closed out — a net gain of 5 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Jane Street, adding an estimated $126K. The largest seller was Schonfeld Strategic Advisors, exiting entirely with an estimated $88.7K sold.

  • 11 institutional investors held Elevai Labs (ELAB) as of Q2 2026, up from 6 in Q1 2026.
  • Funds reported $322K of Elevai Labs stock for Q2 2026, down 17% quarter-over-quarter.
  • 6 funds opened new Elevai Labs positions in Q2 2026 and 1 closed out, a net change of +5 holders.
  • The largest Elevai Labs buyer in Q2 2026 was Jane Street, an estimated $126K added.
  • The largest Elevai Labs seller in Q2 2026 was Schonfeld Strategic Advisors, an estimated $88.7K sold.

Based on aggregated 13F filings for Q2 2026.